This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Urowitz MB, Gladman DD, Tom BD, Ibanez D, Farewell VT. Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus. J Rheumatol. 2008; 35:2152-8.1879300410.3899/jrheum.080214UrowitzMBGladmanDDTomBDIbanezDFarewellVTChanging patterns in mortality and disease outcomes for patients with systemic lupus erythematosus20083521528Search in Google Scholar
Urowitz MB, Gladman D, Ibanez D, Fortin P, Sanchez-Guerrero J, Bae S, et al. Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort. Lupus. 2007; 16:731-5.10.1177/096120330708111317728367UrowitzMBGladmanDIbanezDFortinPSanchez-GuerreroJBaeSet alClinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort2007167315Open DOISearch in Google Scholar
Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA, Jr., Jansen-McWilliams L, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol. 1997; 145:408-15.10.1093/oxfordjournals.aje.a0091229048514ManziSMeilahnENRairieJEConteCGMedsgerTAJrJansen-McWilliamsLet alAge-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study199714540815Open DOISearch in Google Scholar
Barsalou J, Bradley TJ, Silverman ED. Cardiovascular risk in pediatric-onset rheumatological diseases. Arthritis Res Ther. 2013; 15:212.23731870BarsalouJBradleyTJSilvermanEDCardiovascular risk in pediatric-onset rheumatological diseases20131521210.1186/ar4212Search in Google Scholar
Hersh AO, von Scheven E, Yazdany J, Panopalis P, Trupin L, Julian L, et al. Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus. Arthritis Rheum. 2009; 61:13-20.19116979HershAOvonScheven EYazdanyJPanopalisPTrupinLJulianLet alDifferences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus200961132010.1002/art.24091Search in Google Scholar
Gustafsson JT, Svenungsson E. Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus. Autoimmunity. 2014; 47:67-76.10.3109/08916934.2013.85600524228980GustafssonJTSvenungssonEDefinitions of and contributions to cardiovascular disease in systemic lupus erythematosus2014476776Open DOISearch in Google Scholar
Sozeri B, Deveci M, Dincel N, Mir S. The early cardiovascular changes in pediatric patients with systemic lupus erythematosus. Pediatr Nephrol. 2013; 28:471-6.10.1007/s00467-012-2342-223135607SozeriBDeveciMDincelNMirSThe early cardiovascular changes in pediatric patients with systemic lupus erythematosus2013284716Open DOISearch in Google Scholar
Huang YL, Chung HT, Chang CJ, Yeh KW, Chen LC, Huang JL. Lymphopenia is a risk factor in the progression of carotid intima-media thickness in juvenile-onset systemic lupus erythematosus. Arthritis Rheum. 2009; 60:3766-75.10.1002/art.2501919950269HuangYLChungHTChangCJYehKWChenLCHuangJLLymphopenia is a risk factor in the progression of carotid intima-media thickness in juvenile-onset systemic lupus erythematosus200960376675Open DOISearch in Google Scholar
Falaschi F, Ravelli A, Martignoni A, Migliavacca D, Sartori M, Pistorio A, et al. Nephrotic-range proteinuria: the major risk factor for early atherosclerosis in juvenile-onset systemic lupus erythematosus. Arthritis Rheum. 2000; 43:1405-9.1085780110.1002/1529-0131(200006)43:6<1405::AID-ANR26>3.0.CO;2-VFalaschiFRavelliAMartignoniAMigliavaccaDSartoriMPistorioAet alNephrotic-range proteinuria: the major risk factor for early atherosclerosis in juvenile-onset systemic lupus erythematosus20004314059Search in Google Scholar
Bhatt SP, Handa R, Gulati GS, Sharma S, Pandey RM, Aggarwal P, et al. Peripheral vascular disease in systemic lupus erythematosus. Lupus. 2007; 16:720-3.1772836510.1177/0961203307081123BhattSPHandaRGulatiGSSharmaSPandeyRMAggarwalPet alPeripheral vascular disease in systemic lupus erythematosus2007167203Search in Google Scholar
Canpolat N, Kasapcopur O, Caliskan S, Gokalp S, Bor M, Tasdemir M, et al. Ambulatory blood pressure and subclinical cardiovascular disease in patients with juvenile-onset systemic lupus erythematosus. Pediatr Nephrol. 2013; 28:305-13.2305265410.1007/s00467-012-2317-3CanpolatNKasapcopurOCaliskanSGokalpSBorMTasdemirMet alAmbulatory blood pressure and subclinical cardiovascular disease in patients with juvenile-onset systemic lupus erythematosus2013283051323052654Search in Google Scholar
Ortiz TT, Terreri MT, Caetano M, Souza FS, D’Almeida V, Sarni RO, et al. Dyslipidemia in pediatric systemic lupus erythematosus: the relationship with disease activity and plasma homocysteine and cysteine concentrations. Ann Nutr Metab. 2013; 63:77-82.10.1159/00035107623942034OrtizTTTerreriMTCaetanoMSouzaFSD’AlmeidaVSarniROet alDyslipidemia in pediatric systemic lupus erythematosus: the relationship with disease activity and plasma homocysteine and cysteine concentrations201363778223942034Open DOISearch in Google Scholar
Boros CA, Bradley TJ, Cheung MM, Bargman JM, Russell JL, McCrindle BW, et al. Early determinants of atherosclerosis in paediatric systemic lupus erythematosus. Clin Exp Rheumatol. 2011; 29:575-81.21640055BorosCABradleyTJCheungMMBargmanJMRussellJLMcCrindleBWet alEarly determinants of atherosclerosis in paediatric systemic lupus erythematosus20112957581Search in Google Scholar
Ainsworth BE, Haskell WL, Herrmann SD, Meckes N, Bassett DR, Jr., Tudor-Locke C, et al. 2011 Compendium of physical activities: a second update of codes and MET values. Med Sci Sports Exerc. 2011; 43:1575-81.10.1249/MSS.0b013e31821ece1221681120AinsworthBEHaskellWLHerrmannSDMeckesNBassettDRJrTudor-LockeCet al2011 Compendium of physical activities: a second update of codes and MET values20114315758121681120Open DOISearch in Google Scholar
Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc. 2000; 32:S498-504.1099342010.1097/00005768-200009001-00009AinsworthBEHaskellWLWhittMCIrwinMLSwartzAMStrathSJet alCompendium of physical activities: an update of activity codes and MET intensities200032S49850410993420Search in Google Scholar
Boucelma M, Haddoum F, Chaudet H, Kaplanski G, Mazouni-Brahimi N, Rezig-Ladjouze A, et al. Cardiovascular risk and lupus disease. Int Angiol. 2011; 30:18-24.21248669BoucelmaMHaddoumFChaudetHKaplanskiGMazouni-BrahimiNRezig-LadjouzeAet alCardiovascular risk and lupus disease2011301824Search in Google Scholar
Telles RW, Lanna CC, Sousa AJ, Navarro TP, Souza FL, Rodrigues LA, et al. Progression of carotid atherosclerosis in patients with systemic lupus erythematosus. Clin Rheumatol. 2013; 32:1293-300.10.1007/s10067-013-2264-923620348TellesRWLannaCCSousaAJNavarroTPSouzaFLRodriguesLAet alProgression of carotid atherosclerosis in patients with systemic lupus erythematosus201332129330023620348Open DOISearch in Google Scholar
Parker B, Bruce IN. The metabolic syndrome in systemic lupus erythematosus. Rheum Dis Clin North Am. 2010; 36:81-97.10.1016/j.rdc.2009.12.00420202592ParkerBBruceINThe metabolic syndrome in systemic lupus erythematosus201036819720202592Open DOISearch in Google Scholar
Rafieian-Kopaei M, Setorki M, Doudi M, Baradaran A, Nasri H. Atherosclerosis: process, indicators, risk factors and new hopes. Int J Prev Med. 2014; 5:927-46.25489440Rafieian-KopaeiMSetorkiMDoudiMBaradaranANasriHAtherosclerosis: process, indicators, risk factors and new hopes2014592746Search in Google Scholar
Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, et al. Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis. 2012; 34:290-6.TouboulPJHennericiMGMeairsSAdamsHAmarencoPBornsteinNet alMannheim carotid intima-media thickness and plaque consensus (2004-2006-2011)201234290610.1159/000343145376079123128470Search in Google Scholar
Schanberg LE, Sandborg C, Barnhart HX, Ardoin SP, Yow E, Evans GW, et al. Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort. Arthritis Rheum. 2009; 60: 1496-507.1940495310.1002/art.24469SchanbergLESandborgCBarnhartHXArdoinSPYowEEvansGWet alPremature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort2009601496507277072519404953Search in Google Scholar
Bowser CS, Kumar S, Salciccioli L, Kutlin A, Lazar J, Rahim I, et al. Absence of Chlamydia pneumoniae and signs of atherosclerotic cardiovascular disease in adolescents with systemic lupus erythematosus. Pediatr Cardiol. 2008; 29:545-51.10.1007/s00246-007-9131-x18080155BowserCSKumarSSalciccioliLKutlinALazarJRahimIet alAbsence of Chlamydia pneumoniae and signs of atherosclerotic cardiovascular disease in adolescents with systemic lupus erythematosus2008295455118080155Open DOISearch in Google Scholar
Engelen L, Ferreira I, Stehouwer CD, Boutouyrie P, Laurent S. Reference intervals for common carotid intima-media thickness measured with echotracking: relation with risk factors. Eur Heart J. 2013; 34:2368-80.2318680810.1093/eurheartj/ehs380EngelenLFerreiraIStehouwerCDBoutouyriePLaurentSReference intervals for common carotid intima-media thickness measured with echotracking: relation with risk factors20133423688023186808Search in Google Scholar
de Leeuw K, Smit AJ, de Groot E, van Roon AM, Kallenberg C G, Bijl M. Longitudinal study on premature atherosclerosis in patients with systemic lupus erythematosus. Atherosclerosis. 2009; 206:546-50.1938967410.1016/j.atherosclerosis.2009.03.018de LeeuwKSmitAJde GrootEvan RoonAMKallenbergC GBijlMLongitudinal study on premature atherosclerosis in patients with systemic lupus erythematosus20092065465019389674Search in Google Scholar
Viazzi F, Pontremoli R. Blood pressure, albuminuria and renal dysfunction: the ‘chicken or egg’ dilemma. Nephrol Dial Transplant. 2014; 29:1453-5.10.1093/ndt/gfu18324811230ViazziFPontremoliRBlood pressure, albuminuria and renal dysfunction: the ‘chicken or egg’ dilemma2014291453524811230Open DOISearch in Google Scholar
Tongma C, Shikuma CM, Nakamoto BK, Kallianpur KJ, Umaki TM, Barbour JD, et al. Albuminuria as a marker of cardiovascular risk in HIV-infected individuals receiving stable antiretroviral therapy. Hawaii J Med Public Health. 2013; 72:34-8.24052917TongmaCShikumaCMNakamotoBKKallianpurKJUmakiTMBarbourJDet alAlbuminuria as a marker of cardiovascular risk in HIV-infected individuals receiving stable antiretroviral therapy201372348Search in Google Scholar
Ma H, Lin H, Hofman A, Hu Y, Li X, He W, et al. Low-grade albuminuria is associated with carotid atherosclerosis in normotensive and euglycemic Chinese middle-aged and elderly adults: the Shanghai Changfeng Study. Atherosclerosis. 2013; 228:237-42.2345335110.1016/j.atherosclerosis.2013.02.007MaHLinHHofmanAHuYLiXHeWet alLow-grade albuminuria is associated with carotid atherosclerosis in normotensive and euglycemic Chinese middle-aged and elderly adults: the Shanghai Changfeng Study20132282374223453351Search in Google Scholar
Yang L, Tao J, Tang X, Wang Y, He X, Xu G, et al. Prevalence and correlation of conventional and lupus-specific risk factors for cardiovascular disease in Chinese systemic lupus erythematosus patients. J Eur Acad Dermatol Venereol. 2012; 26:95-101.2185142410.1111/j.1468-3083.2011.04211.xYangLTaoJTangXWangYHeXXuGet alPrevalence and correlation of conventional and lupus-specific risk factors for cardiovascular disease in Chinese systemic lupus erythematosus patients2012269510121851424Search in Google Scholar
Iaccarino L, Bettio S, Zen M, Nalotto L, Gatto M, Ramonda R, et al. Premature coronary heart disease in SLE: can we prevent progression? Lupus. 2013; 22: 1232-42.10.1177/096120331349287124097995IaccarinoLBettioSZenMNalottoLGattoMRamondaRet alPremature coronary heart disease in SLE: can we prevent progression?20132212324224097995Open DOISearch in Google Scholar
Bertsias GK, Tektonidou M, Amoura Z, Aringer M, Bajema I, Berden JH, et al. Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis. 2012; 71:1771-82.2285146910.1136/annrheumdis-2012-201940BertsiasGKTektonidouMAmouraZAringerMBajemaIBerdenJHet alJoint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis201271177182346585922851469Search in Google Scholar
Kockx M, Jessup W, Kritharides L. Cyclosporin A and atherosclerosis – cellular pathways in atherogenesis. Pharmacol Ther. 2010; 128:106-18.10.1016/j.pharmthera.2010.06.00120598751KockxMJessupWKritharidesLCyclosporin A and atherosclerosis – cellular pathways in atherogenesis20101281061820598751Open DOISearch in Google Scholar
Sazliyana S, Mohd Shahrir MS, Kong CT, Tan HJ, Hamidon BB, Azmi MT. Implications of immuno-suppressive agents in cardiovascular risks and carotid intima media thickness among lupus nephritis patients. Lupus. 2011; 20:1260-6.10.1177/0961203311411347SazliyanaSMohd ShahrirMSKongCTTanHJHamidonBBAzmiMTImplications of immuno-suppressive agents in cardiovascular risks and carotid intima media thickness among lupus nephritis patients2011201260621844115Open DOISearch in Google Scholar
Oryoji K, Kiyohara C, Horiuchi T, Tsukamoto H, Niiro H, Shimoda T, et al. Reduced carotid intima-media thickness in systemic lupus erythematosus patients treated with A. Mod Rheumatol. 2014; 24:86-92.2426176310.3109/14397595.2013.852838OryojiKKiyoharaCHoriuchiTTsukamotoHNiiroHShimodaTet alReduced carotid intima-media thickness in systemic lupus erythematosus patients treated with A201424869224261763Search in Google Scholar